Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-020288

Chief Medical Officer sold 10,000 shares at an average $64.16 ($641,615)

  • Chief Medical Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bowden Christopher Chief Medical Officer 2019-03-15 Option exercise +10,000 $35.16 $351,600 17,238 D
Bowden Christopher Chief Medical Officer 2019-03-15 Sale −8,700 $64.09 $557,583 8,538 D
Bowden Christopher Chief Medical Officer 2019-03-15 Sale −1,300 $64.64 $84,032 7,238 D
Derivatives
Bowden Christopher Chief Medical Officer 2019-03-15 Option exercise · Stock option (right to buy) −10,000 81,000 D
Open-market sales · 10,000 sh · avg $64.16 · $641,615
Loading xslF345X03/doc4.xml…